Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Ticagrelor with or without Aspirin in High-Risk Patients after PCI.

Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, Cha JY, Collier T, Dangas G, Dudek D, Džavík V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta SR, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM.

N Engl J Med. 2019 Sep 26. doi: 10.1056/NEJMoa1908419. [Epub ahead of print]

PMID:
31556978
2.

Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.

Plitt A, Claessen BE, Sartori S, Baber U, Chandrasekhar J, Aquino M, Vijay P, Elsayed S, Kovacic JC, Sweeny J, Barman N, Moreno P, Krishnan P, Demopoulos A, Dangas G, Kini AS, Mehran R, Sharma SK.

Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488. [Epub ahead of print]

PMID:
31490029
3.

Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative.

Farhan S, Baber U, Vogel B, Aquino M, Giustino G, Chandrasekhar J, Sorrentino S, Guedeney P, Manzanilla G, Bunal N, Rassouli M, Barman N, Sweeny J, Khan A, Dangas G, Mehran R, Kini A, Sharma SK.

Eur J Prev Cardiol. 2019 Sep 3:2047487319874150. doi: 10.1177/2047487319874150. [Epub ahead of print] No abstract available.

PMID:
31480872
4.

Reply: DAPT Cessation and MACE in Elderly Patients: What Is the Optimal Regimen and Duration?

Joyce L, Baber U, Mehran R.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1627-1628. doi: 10.1016/j.jcin.2019.06.041. No abstract available.

PMID:
31439345
5.

Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry.

Vogel B, Chandrasekhar J, Baber U, Mastoris I, Sartori S, Aquino M, Krucoff MW, Moliterno DJ, Henry TD, Weisz G, Gibson CM, Iakovou I, Kini AS, Farhan S, Sorrentino S, Faggioni M, Colombo A, Steg PG, Witzenbichler B, Chieffo A, Cohen DJ, Stuckey T, Ariti C, Dangas GD, Pocock S, Mehran R.

Thromb Haemost. 2019 Oct;19(10):1704-1711. doi: 10.1055/s-0039-1693463. Epub 2019 Jul 31.

PMID:
31365942
6.

Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.

Baber U, Stefanini GG, Giustino G, Stone GW, Leon MB, Sartori S, Aquino M, Steg PG, Windecker S, Wijns W, Serruys PW, Valgimigli M, Morice MC, Camenzind E, Weisz G, Smits PC, Kandzari DE, von Birgelen C, Dangas GD, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Mehran R.

Circ Cardiovasc Interv. 2019 Jul;12(7):e007734. doi: 10.1161/CIRCINTERVENTIONS.118.007734. Epub 2019 Jul 10.

PMID:
31288561
7.

Negative Risk Markers for Cardiovascular Events in the Elderly.

Mortensen MB, Fuster V, Muntendam P, Mehran R, Baber U, Sartori S, Falk E.

J Am Coll Cardiol. 2019 Jul 9;74(1):1-11. doi: 10.1016/j.jacc.2019.04.049.

PMID:
31272534
8.

Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.

Guedeney P, Giustino G, Sorrentino S, Claessen BE, Camaj A, Kalkman DN, Vogel B, Sartori S, De Rosa S, Baber U, Indolfi C, Montalescot G, Dangas GD, Rosenson RS, Pocock SJ, Mehran R.

Eur Heart J. 2019 Jul 3. pii: ehz430. doi: 10.1093/eurheartj/ehz430. [Epub ahead of print]

PMID:
31270529
9.

Incidence, determinants and impact of acute kidney injury in patients with diabetes mellitus and multivessel disease undergoing coronary revascularization: Results from the FREEDOM trial.

Arbel Y, Fuster V, Baber U, Hamza TH, Siami FS, Farkouh ME.

Int J Cardiol. 2019 Oct 15;293:197-202. doi: 10.1016/j.ijcard.2019.05.064. Epub 2019 Jun 13.

PMID:
31230933
10.

Corrigendum to "Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry" [Int. J. Cardiol. 283 (2019) 67-72].

Colombo A, Chandrasekhar J, Aquino M, Ong TK, Sartori S, Baber U, Lee M, Iniguez A, Hajek P, Borisov B, Atzev B, Heijer PD, Coufal Z, Hudec M, Mates M, Snyder C, Moalem K, Morrell D, Elmore F, Rowland S, Mehran R; MASCOT Investigators.

Int J Cardiol. 2019 Oct 1;292:285. doi: 10.1016/j.ijcard.2019.04.075. Epub 2019 Jun 18. No abstract available.

PMID:
31227412
11.

Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.

Chandiramani R, Chen H, Aoi S, Giustino G, Claessen B, Sartori S, Aquino M, Sorrentino S, Cao D, Goel R, Kini A, Rao S, Weintraub W, Henry TD, Kapadia S, DeFranco A, Muhlestein JB, Toma C, Effron MB, Keller S, Baker BA, Pocock S, Baber U, Mehran R.

Catheter Cardiovasc Interv. 2019 Jun 14. doi: 10.1002/ccd.28369. [Epub ahead of print]

PMID:
31197962
12.

Stent Expansion and Endothelial Shear Stress in Bifurcation Lesions.

Okamoto N, Vengrenyuk Y, Bhatheja S, Chamaria S, Khan A, Gupta E, Kapur V, Barman N, Hasan C, Sweeny J, Baber U, Mehran R, Narula J, Sharma SK, Kini AS.

Circ Cardiovasc Interv. 2019 Jun;12(6):e007911. doi: 10.1161/CIRCINTERVENTIONS.119.007911. Epub 2019 Jun 14. No abstract available.

PMID:
31195824
13.

Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry.

Joyce LC, Baber U, Claessen BE, Sartori S, Chandrasekhar J, Cohen DJ, Henry TD, Ariti C, Dangas G, Faggioni M, Aoi S, Gibson CM, Aquino M, Krucoff MW, Vogel B, Moliterno DJ, Sorrentino S, Colombo A, Chieffo A, Kini A, Guedeney P, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

JACC Cardiovasc Interv. 2019 May 27;12(10):983-992. doi: 10.1016/j.jcin.2019.02.033.

PMID:
31122354
14.

Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.

Guedeney P, Claessen BE, Kalkman DN, Aquino M, Sorrentino S, Giustino G, Farhan S, Vogel B, Sartori S, Montalescot G, Sweeny J, Kovacic JC, Krishnan P, Barman N, Dangas G, Kini A, Baber U, Sharma S, Mehran R.

J Am Coll Cardiol. 2019 May 21;73(19):2401-2409. doi: 10.1016/j.jacc.2019.01.077. Erratum in: J Am Coll Cardiol. 2019 Jul 23;74(3):481-482.

PMID:
31097159
15.

Clinical trials in long-term antiplatelet therapies: focus on the role of aspirin.

Goel R, Baber U.

Curr Opin Cardiol. 2019 Jul;34(4):315-322. doi: 10.1097/HCO.0000000000000640.

PMID:
31082853
16.

Outcomes by Gender and Ethnicity After Percutaneous Coronary Intervention.

Mahajan AM, Claessen BE, Chandrasekhar J, Sartori S, Aquino M, Baber U, Dangas G, Kovacic JC, Krishnan P, Moreno P, Sweeny J, Barman N, Vijay P, Kini A, Mehran R, Sharma S.

Am J Cardiol. 2019 Jun 15;123(12):1941-1948. doi: 10.1016/j.amjcard.2019.03.019. Epub 2019 Mar 19.

PMID:
31005238
17.

Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.

Faggioni M, Baber U, Sartori S, Chandrasekhar J, Cohen DJ, Henry TD, Claessen BE, Dangas GD, Gibson CM, Krucoff MW, Vogel B, Moliterno DJ, Sorrentino S, Colombo A, Chieffo A, Kini A, Farhan S, Ariti C, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007133. doi: 10.1161/CIRCINTERVENTIONS.118.007133.

PMID:
30998384
18.

Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration.

Camaj A, Giustino G, Claessen BE, Baber U, Power DA, Sartori S, Aquino M, Stone GW, Windecker S, Dangas G, Mehran R.

Int J Cardiol. 2019 Jul 15;287:59-61. doi: 10.1016/j.ijcard.2019.03.034. Epub 2019 Mar 19.

PMID:
30982549
19.

Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Guedeney P, Claessen BE, Baber U, Camaj A, Sorrentino S, Aquino M, Blum M, Chandiramani R, Goel R, Elsayed S, Kovacic JC, Sweeny J, Barman N, Moreno P, Dangas GD, Kini A, Sharma S, Mehran R.

Am J Cardiol. 2019 Jun 1;123(11):1788-1795. doi: 10.1016/j.amjcard.2019.03.005. Epub 2019 Mar 9.

PMID:
30955866
20.

Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry.

Ge Z, Baber U, Claessen BE, Chandrasekhar J, Chandiramani R, Li SX, Sartori S, Kini AS, Rao SV, Weiss S, Henry TD, Kapadia S, Muhlestein B, Strauss C, Toma C, DeFranco A, Effron MB, Keller S, Baker BA, Pocock S, Dangas G, Mehran R.

J Thromb Thrombolysis. 2019 Jul;48(1):42-51. doi: 10.1007/s11239-019-01842-9.

PMID:
30924052
21.

Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention.

Farhan S, Vogel B, Baber U, Sartori S, Aquino M, Chandrasekhar J, Sorrentino S, Giustino G, Sharma M, Guedeney P, Rohla M, Bhandari R, Barman N, Sweeny J, Dangas G, Mehran R, Kini A, Sharma S.

Cardiorenal Med. 2019;9(3):160-167. doi: 10.1159/000494807. Epub 2019 Mar 7.

PMID:
30844810
22.

Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.

Colombo A, Chandrasekhar J, Aquino M, Ong TK, Sartori S, Baber U, Lee M, Iniguez A, Hajek P, Borisov B, Atzev B, Den Heijer P, Coufal Z, Hudec M, Mates M, Snyder C, Moalem K, Morrell D, Elmore F, Rowland S, Mehran R; MASCOT Investigators.

Int J Cardiol. 2019 May 15;283:67-72. doi: 10.1016/j.ijcard.2019.01.053. Epub 2019 Jan 21. Erratum in: Int J Cardiol. 2019 Jun 18;:.

PMID:
30826192
23.

Deep learning for cardiovascular medicine: a practical primer.

Krittanawong C, Johnson KW, Rosenson RS, Wang Z, Aydar M, Baber U, Min JK, Tang WHW, Halperin JL, Narayan SM.

Eur Heart J. 2019 Jul 1;40(25):2058-2073. doi: 10.1093/eurheartj/ehz056.

PMID:
30815669
24.

Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.

Atti V, Patel NJ, Kumar V, Tripathi B, Basir MB, Voeltz M, Baber U, Kini AS, Sharma SK, O'Neill WW, Bhatt DL.

Catheter Cardiovasc Interv. 2019 Aug 1;94(2):E67-E77. doi: 10.1002/ccd.28161. Epub 2019 Feb 27.

PMID:
30811833
25.

Safety and Efficacy of Polymer-Free Drug-Eluting Stents.

Chiarito M, Sardella G, Colombo A, Briguori C, Testa L, Bedogni F, Fabbiocchi F, Paggi A, Palloshi A, Tamburino C, Margonato A, Pivato CA, Baber U, Calcagno S, Giordano A, Godino C, Stefanini GG.

Circ Cardiovasc Interv. 2019 Feb;12(2):e007311. doi: 10.1161/CIRCINTERVENTIONS.118.007311.

PMID:
30767663
26.

Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry.

Mehilli J, Chandrasekhar J, Sartori S, Chieffo A, Petronio AS, Lefèvre T, Presbitero P, Capranzano P, Tchetche D, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Jochheim D, Zadrozny M, Mikhail GW, Sharma S, Ferrer MC, Naber C, Kievit P, Moalem K, Baber U, Snyder C, Sharma M, Morice MC, Mehran R; Women’s INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) Investigators.

Can J Cardiol. 2019 Feb;35(2):199-207. doi: 10.1016/j.cjca.2018.11.035. Epub 2018 Dec 12.

PMID:
30760427
27.

Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.

Faggioni M, Baber U, Chandrasekhar J, Sartori S, Weintraub W, Rao SV, Vogel B, Claessen B, Kini A, Effron M, Ge Z, Keller S, Strauss C, Snyder C, Toma C, Weiss S, Aquino M, Baker B, Defranco A, Bansilal S, Muhlestein B, Kapadia S, Pocock S, Poddar KL, Henry TD, Mehran R.

Catheter Cardiovasc Interv. 2019 Jul 1;94(1):53-60. doi: 10.1002/ccd.28033. Epub 2019 Jan 17.

PMID:
30656812
28.

Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.

Schoos M, Power D, Baber U, Sartori S, Claessen B, Camaj A, Steg P, Ariti C, Weisz G, Witzenbichler B, Henry T, Cohen D, Antoniucci D, Krucoff M, Hermiller J, Gibson C, Chieffo A, Moliterno D, Colombo A, Pocock S, Dangas G, Mehran R.

Am J Cardiol. 2019 Mar 1;123(5):709-716. doi: 10.1016/j.amjcard.2018.11.051. Epub 2018 Dec 4.

PMID:
30612724
29.

Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry.

Moalem K, Baber U, Chandrasekhar J, Claessen BE, Sartori S, Aquino M, Dangas G, Iakovou I, Colombo A, Kini A, Gibson M, Krucoff M, Chieffo A, Moliterno D, Witzenbichler B, Pocock S, Mehran R.

Clin Res Cardiol. 2019 Jun;108(6):643-650. doi: 10.1007/s00392-018-1392-2. Epub 2019 Jan 3.

PMID:
30607496
30.

Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.

Baber U, Leisman DE, Cohen DJ, Gibson CM, Henry TD, Dangas G, Moliterno D, Kini A, Krucoff M, Colombo A, Chieffo A, Sartori S, Witzenbichler B, Steg PG, Pocock SJ, Mehran R.

Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004945. doi: 10.1161/CIRCOUTCOMES.118.004945.

PMID:
30606052
31.

The Challenge of Diabetes Mellitus in the Contemporary Percutaneous Coronary Intervention Era: Are We Making Progress?

Baber U.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2477-2479. doi: 10.1016/j.jcin.2018.10.027. No abstract available.

PMID:
30573058
32.

Left Main PCI With DES Versus CABG: Cautionary Note or Cause for Concern?

Baber U, Dangas GD.

J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2823-2825. doi: 10.1016/j.jacc.2018.09.058. No abstract available.

PMID:
30522645
33.

Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.

Guedeney P, Tchétché D, Petronio AS, Mehilli J, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Iadanza A, Sardella G, Van Mieghem NM, Sorrentino S, Claessen BEPM, Chandrasekhar J, Vogel B, Kalkman DN, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer-Grazia MC, Naber C, Kievit P, Baber U, Sharma S, Morice MC, Chieffo A, Mehran R; WIN TAVI Investigators.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1124-1131. doi: 10.1002/ccd.28012. Epub 2018 Dec 4.

PMID:
30511802
34.

Predictors of side branch compromise in calcified bifurcation lesions treated with orbital atherectomy.

Barman N, Okamoto N, Ueda H, Chamaria S, Bhatheja S, Vengrenyuk Y, Gupta E, Sweeny J, Kapur V, Hasan C, Baber U, Moreno P, Sharma S, Kini AS.

Catheter Cardiovasc Interv. 2019 Jul 1;94(1):45-52. doi: 10.1002/ccd.27992. Epub 2018 Dec 3.

PMID:
30511359
35.

Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention: Results from a large single-center prospective registry.

Guedeney P, Baber U, Claessen B, Aquino M, Camaj A, Sorrentino S, Vogel B, Farhan S, Faggioni M, Chandrasekhar J, Kalkman DN, Kovacic JC, Sweeny J, Barman N, Moreno P, Vijay P, Shah S, Dangas G, Kini A, Sharma S, Mehran R.

Am Heart J. 2019 Jan;207:10-18. doi: 10.1016/j.ahj.2018.09.001. Epub 2018 Sep 12.

PMID:
30404046
36.

Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention.

Faggioni M, Baber U, Chandrasekhar J, Sartori S, Claessen BE, Rao SV, Vogel B, Effron MB, Poddar K, Farhan S, Kini A, Weintraub W, Toma C, Sorrentino S, Weiss S, Snyder C, Muhlestein JB, Kapadia S, Keller S, Strauss C, Aquino M, Baker B, Defranco A, Pocock S, Henry T, Mehran R.

Int J Cardiol. 2019 Jan 15;275:31-35. doi: 10.1016/j.ijcard.2018.10.071. Epub 2018 Oct 25.

PMID:
30391067
37.

DNA Sequence Variation in ACVR1C Encoding the Activin Receptor-Like Kinase 7 Influences Body Fat Distribution and Protects Against Type 2 Diabetes.

Emdin CA, Khera AV, Aragam K, Haas M, Chaffin M, Klarin D, Natarajan P, Bick A, Zekavat SM, Nomura A, Ardissino D, Wilson JG, Schunkert H, McPherson R, Watkins H, Elosua R, Bown MJ, Samani NJ, Baber U, Erdmann J, Gupta N, Danesh J, Saleheen D, Gabriel S, Kathiresan S.

Diabetes. 2019 Jan;68(1):226-234. doi: 10.2337/db18-0857. Epub 2018 Nov 2.

38.

Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation.

Sorrentino S, Baber U, Mehran R.

Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):192-194. doi: 10.1016/j.rec.2018.10.002. Epub 2018 Oct 30. English, Spanish. No abstract available.

PMID:
30389238
39.

Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.

Kalkman DN, Aquino M, Claessen BE, Baber U, Guedeney P, Sorrentino S, Vogel B, de Winter RJ, Sweeny J, Kovacic JC, Shah S, Vijay P, Barman N, Kini A, Sharma S, Dangas GD, Mehran R.

Eur Heart J. 2018 Dec 7;39(46):4101-4108. doi: 10.1093/eurheartj/ehy633.

PMID:
30358832
40.

Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis.

Varghese MJ, Bhatheja S, Baber U, Kezbor S, Chincholi A, Chamaria S, Buckstein M, Bakst R, Kini A, Sharma S.

Circ Cardiovasc Interv. 2018 Oct;11(10):e006832. doi: 10.1161/CIRCINTERVENTIONS.118.006832.

PMID:
30354630
41.

The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.

Ge Z, Baber U, Claessen BE, Farhan S, Chandrasekhar J, Li SX, Sartori S, Kini AS, Rao SV, Weiss S, Henry TD, Vogel B, Sorrentino S, Faggioni M, Kapadia S, Muhlestein B, Strauss C, Toma C, DeFranco A, Effron MB, Keller S, Baker BA, Pocock S, Dangas G, Mehran R.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):E112-E119. doi: 10.1002/ccd.27860. Epub 2018 Oct 23.

PMID:
30351514
42.

Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease.

Guedeney P, Sorrentino S, Vogel B, Baber U, Claessen BE, Mehran R.

Expert Rev Cardiovasc Ther. 2018 Nov;16(11):825-835. doi: 10.1080/14779072.2018.1526082. Epub 2018 Oct 16. Review.

PMID:
30324814
43.

Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).

Guedeney P, Chieffo A, Snyder C, Mehilli J, Petronio AS, Claessen BE, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Tchétché D, Iadanza A, Sardella G, Van Mieghem NM, Chandrasekhar J, Vogel B, Sorrentino S, Kalkman DN, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer MC, Naber C, Kievit P, Baber U, Sharma S, Morice MC, Mehran R; WIN-TAVI Investigators.

Am J Cardiol. 2018 Dec 1;122(11):1909-1916. doi: 10.1016/j.amjcard.2018.08.036. Epub 2018 Sep 8.

PMID:
30318417
44.

Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.

Sorrentino S, Baber U, Claessen BE, Camaj A, Vogel B, Sartori S, Guedeney P, Chandrasekhar J, Farhan S, Barman N, Sweeny J, Giustino G, Dangas G, Kini A, Sharma S, Mehran R.

Thromb Haemost. 2018 Nov;118(11):1997-2005. doi: 10.1055/s-0038-1673687. Epub 2018 Oct 12.

PMID:
30312975
45.

1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.

de Winter RJ, Chandrasekhar J, Kalkman DN, Aquino MB, Woudstra P, Beijk MA, Sartori S, Baber U, Tijssen JG, Koch KT, Dangas GD, Colombo A, Mehran R; MASCOT; REMEDEE Registry Investigators.

JACC Cardiovasc Interv. 2018 Oct 8;11(19):1969-1978. doi: 10.1016/j.jcin.2018.04.038.

46.

Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry).

Sorrentino S, Giustino G, Baber U, Sartori S, Cohen DJ, Henry TD, Farhan S, Sharma M, Ariti C, Dangas G, Gibson M, Faggioni M, Krucoff MW, Aquino M, Chandrasekhar J, Moliterno DJ, Colombo A, Vogel B, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

Am J Cardiol. 2018 Nov 15;122(10):1638-1646. doi: 10.1016/j.amjcard.2018.07.041. Epub 2018 Aug 20.

PMID:
30270177
47.

Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial.

Van Mieghem NM, Unverdorben M, Valgimigli M, Mehran R, Boersma E, Baber U, Hengstenberg C, Shi M, Chen C, Saito S, Veltkamp R, Vranckx P, Dangas GD.

Am Heart J. 2018 Nov;205:63-69. doi: 10.1016/j.ahj.2018.07.006. Epub 2018 Aug 29.

PMID:
30172099
48.

Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients.

Baber U, Bouley A, Egnor E, Sloane JA.

J Neurol. 2018 Oct;265(10):2342-2345. doi: 10.1007/s00415-018-8996-3. Epub 2018 Aug 14.

PMID:
30109480
49.

Defining PCI complexity in the contemporary DES era: Clarity or confusion?

Baber U.

Int J Cardiol. 2018 Oct 1;268:94-95. doi: 10.1016/j.ijcard.2018.05.044. No abstract available.

PMID:
30041807
50.

Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).

Valgimigli M, Garcia-Garcia HM, Vrijens B, Vranckx P, McFadden EP, Costa F, Pieper K, Vock DM, Zhang M, Van Es GA, Tricoci P, Baber U, Steg G, Montalescot G, Angiolillo DJ, Serruys PW, Farb A, Windecker S, Kastrati A, Colombo A, Feres F, Jüni P, Stone GW, Bhatt DL, Mehran R, Tijssen JGP.

Eur Heart J. 2019 Jul 1;40(25):2070-2085. doi: 10.1093/eurheartj/ehy377.

PMID:
29992264

Supplemental Content

Support Center